Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02614079 · ClinicalTrials.gov registry record · NA
Evaluation of the Percutaneous SCS Trial Using the DSSEP Collision Testing
A NA study, sponsored by University of Toledo Health Science Campus.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02614079: Clinical Trial NA study, sponsored by University of Toledo Health Science Campus.
NCT02614079 is a NA study that was terminated before completion, run by University of Toledo Health Science Campus. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02614079, a NA study, was terminated before completion, sponsored by University of Toledo Health Science Campus.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study is to objectively evaluate the success of a spinal cord stimulator (SCS) trial using testing (DSSEP) to determine if the paresthesia (tingling sensation) or pain reduction achieved correlates with the degree of stimulation.
Primary Outcome
Positive collision: 75% or greater decrease in amplitude from the baseline waveform. Centroparietal (CPz)-Popliteal Fossa (Fpz) cortical montage (images) will be used as primary montage to evaluate collision results.
Interventions
- DEVICE DSSEP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-01-20 |
| Est. Completion | 2017-11-09 |
| Phase | NA |
Why NCT02614079 stopped before completion
NCT02614079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which DSSEP is the first listed.
NCT02614079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02614079 about?
NCT02614079 is a clinical study titled "Evaluation of the Percutaneous SCS Trial Using the DSSEP Collision Testing". This study is to objectively evaluate the success of a spinal cord stimulator (SCS) trial using testing (DSSEP) to determine if the paresthesia (tingling sensation) or pain reduction achieved correlates with the degree of stimulation.
What is the current status of trial NCT02614079?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2016-01-20. Estimated completion is 2017-11-09.
What interventions are being tested in trial NCT02614079?
The interventions under investigation include: DSSEP (DEVICE).
Who is sponsoring clinical trial NCT02614079?
This trial is sponsored by University of Toledo Health Science Campus, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02614079's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI